SAN DIEGO and SUZHOU, China — August 26, 2025 — Leads & Copy — Adagene Inc. announced that its Chief Strategy Officer, Mickael Chane-Du, will participate in investor meetings and a fireside chat at two investor conferences in New York in September.
The H.C. Wainwright 27th Annual Global Investment Conference will feature a fireside chat on Monday, September 8, at 11:00 AM (Eastern Time) at the Lotte New York Palace Hotel. A webcast is available at https://journey.ct.events/view/5c4a1cf5-b8ef-4b48-ae46-3a0f5912b3ca.
The Morgan Stanley 23rd Annual Global Healthcare Conference will host a fireside chat on Wednesday, September 10, at 7:00 AM (Eastern Time) at the Sheraton New York Times Square Hotel. The webcast can be accessed at https://cc.webcasts.com/morg007/090825a_js/?entity=139_6SK4L3R.
Webcasts of the presentations will be available in the Investors section of Adagene’s website for at least 30 days.
Adagene Inc. (Nasdaq: ADAG) is a clinical-stage biotechnology company focused on discovering and developing antibody-based cancer immunotherapies, combining computational biology and AI. Its pipeline features novel immunotherapy programs, including ADG126 (muzastotug), a masked, anti-CTLA-4 SAFEbody in phase 1b/2 clinical studies.
Investor Contacts:
Raymond Tam
raymond_tam@adagene.com
Corey Davis
LifeSci Advisors
cdavis@lifesciadvisors.com
Source: Adagene Inc.
